.classification { position: relative; width: 91px; height: 17px; } .classification .cover { position: absolute; background: transparent url(stars.png) top left no-repeat; top: 0px; left: 0px; width: 91px; height: 17px; z-index: 101; } .classification .progress { position: absolute; background: transparent url(stars_full.png) top left no-repeat; top: 0px; left: 0px; height: 17px; z-index: 102; } -->

Sunday, September 18, 2011

Review: The Quest for the Cure by Brent R. Stockwell

Brent R. Stockwell takes the reader through on a journey through the history and future of drug development in his book The Quest for the Cure: The Science and Stories Behind the Next Generation of Medicines.


It is written in a very accessible style and so is open to both those with a scientific background and those who do not. Although a basic grasp of biology will ease things along. As well as dealing with the science of drug development Stockwell also deals with the business side of the pharmaceutical industry, a combination lacking in similar books. I was particularly interested in his exploration of the role of ‘undruggable’ proteins in diseases such as cancer, and how these pose an issue for drug developers. Professor Stockwell’s expertise in this area clearly shows and I especially liked the many anecdotes from his own work that were included.

Overall this is a very interesting and up to date book, which although aimed at those with an academic/professional interest in the topic, is accessible to a much wider audience. It was of particular interest to me as I trained in a field closely related to drug development.

The Quest for the Cure: The Science and Stories Behind the Next Generation of Medicines is available from Amazon UK for £8.51, from Amazon US for $13.66 and from WH Smith for £17.75.

[Columbia University Press provided a review copy] 

No comments:

Post a Comment